Mert Sahin, PhD, is a distinguished expert in diagnostics and life sciences, focusing on the development and commercialization of innovative diagnostic solutions for neurodegenerative diseases, including Alzheimer's, Parkinson's, Multiple Sclerosis, and Gout. He earned his PhD in Cell Biology and Neuroscience from the University of Hamburg in 2006 and has a strong background in solving complex problems, mentorship, and entrepreneurship. Mert's career includes significant contributions at GE Healthcare, where he provided development and optimization services for biopharmaceuticals targeting neurodegenerative diseases. His published works include his PhD thesis and multiple whitepapers. Outside of his professional endeavors, he is passionate about martial arts (practicing Taekwondo and Wing Chun), traveling, and cooking. Mert's future goals involve scaling his start-up to successful operational status while continuing to advance diagnostic capabilities for critical diseases. His philosophy emphasizes curiosity, a hunger for knowledge, and a love for change.